Skip to main content

Sangamo Therapeutics, Inc 10-Q for FY2025 Q2

Sangamo Therapeutics, Inc (SGMOQ)

10-Q 2025-08-07 For: 2025-06-30
View Original
Added on April 10, 2026

About this 10-Q

Sangamo Therapeutics, Inc filed this 10-Q on August 7, 2025, covering the quarter ended June 30, 2025 (FY2025 Q2).

Headline figures

Quarter ended June 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$18.31M
up 5042.1% from $356K a year earlier
Net loss
$19.99M
compared with a net loss of $36.13M a year earlier
Diluted EPS
-$0.08
compared with -$0.18 a year earlier